Document:

EX-10.5

 Exhibit 10.5 

BioPlus Acquisition Corp. 

533 Airport Blvd 
 Suite
400 
 Burlingame, CA 94010 

March 18, 2021 
 BioPlus Acquisition Corp. 

533 Airport Blvd 
 Suite 400 

Burlingame, CA 94010 
  

	RE:	 Securities Subscription Agreement 

Ladies and Gentlemen: 
 BioPlus Acquisition
Corp., a Cayman Islands exempted company (the “Company”), is pleased to accept the offer BioPlus Sponsor LLC, a Cayman Islands limited liability company (the “Subscriber” or “you”), has made to
subscribe for 6,325,000 Class B ordinary shares of the Company (the “Shares”), $0.0001 par value per share (the “Class B Shares”), up to 825,000 of which are subject to surrender and
cancellation by you if the underwriters of the Company’s initial public offering (“IPO”) of units (“Units”) do not fully exercise their over-allotment option (the “Over-allotment Option”). For
the purposes of this Agreement, references to “Ordinary Shares” are to, collectively, the Class B Shares and the Company’s Class A ordinary shares, $0.0001 par value per share (the “Class A
Shares”). Pursuant to the Company’s memorandum and articles of association (the “Articles”), Class B Shares will convert into Class A shares on a one-for-one basis, subject to adjustment, upon the terms and conditions set forth in the Articles. Unless the context otherwise requires, as used herein “Shares” shall be deemed to include any
Class A Shares issued upon conversion of the Class B Shares comprising the Shares. The terms (this “Agreement”) on which the Company is willing to issue the Shares to the Subscriber, and the Company and the
Subscriber’s agreements regarding such Shares, are as follows: 
 1. Subscription for Shares. 

For the sum of $25,000 (the “Purchase Price”), which the Company acknowledges receiving in cash, the Company hereby issues the
Shares to the Subscriber, and the Subscriber hereby subscribes for and purchases the Shares from the Company, 825,000 of which are subject to surrender and cancellation, on the terms and subject to the conditions set forth in this Agreement.
Concurrently with the Subscriber’s execution of this Agreement, the Company shall update its Register of Members accordingly. All references in this Agreement to shares of the Company being surrendered and cancelled shall take effect as
surrenders and cancellations for no consideration of such shares as a matter of Cayman Islands law. Upon the issuance of the Shares, the Subscriber surrenders for no consideration the one Class A ordinary share of the Company currently held by
it following the incorporation of the Company. 
 2. Representations, Warranties and Agreements. 

2.1 Subscriber’s Representations, Warranties and Agreements. To induce the Company to issue the Shares to the Subscriber, the
Subscriber hereby represents and warrants to the Company and agrees with the Company as follows: 

 2.1.1 No Government Recommendation or Approval. The Subscriber understands that no
federal or state agency has passed upon or made any recommendation or endorsement of the offering of the Shares. 
 2.1.2 No
Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Subscriber of the transactions contemplated hereby do not violate, conflict with or constitute a default under (i) the formation and governing
documents of the Subscriber, (ii) any agreement, indenture or instrument to which the Subscriber is a party or (iii) any law, statute, rule or regulation to which the Subscriber is subject, or any agreement, order, judgment or decree to
which the Subscriber is subject. 
 2.1.3 Organization and Authority. The Subscriber is a Cayman Islands limited liability company,
validly existing and in good standing under the laws of the Cayman Islands and possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement. Upon execution and delivery by you, this Agreement
will be a legal, valid and binding agreement of Subscriber, enforceable against Subscriber in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance or similar laws
affecting the enforcement of creditors’ rights generally and subject to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity). 

2.1.4 Experience, Financial Capability and Suitability. Subscriber is: (i) sophisticated in financial matters and is able to
evaluate the risks and benefits of the investment in the Shares and (ii) able to bear the economic risk of its investment in the Shares for an indefinite period of time because the Shares have not been registered under the Securities Act (as
defined below) and therefore cannot be sold unless subsequently registered under the Securities Act or an exemption from such registration is available. Subscriber is capable of evaluating the merits and risks of its investment in the Company and
has the capacity to protect its own interests. Subscriber must bear the economic risk of this investment until the Shares are sold pursuant to: (i) an effective registration statement under the Securities Act or (ii) an exemption from
registration available with respect to such sale. Subscriber is able to bear the economic risks of an investment in the Shares and to afford a complete loss of Subscriber’s investment in the Shares. 

2.1.5 Access to Information; Independent Investigation. Prior to the execution of this Agreement, the Subscriber has had the
opportunity to ask questions of and receive answers from representatives of the Company concerning an investment in the Company, as well as the finances, operations, business and prospects of the Company, and the opportunity to obtain additional
information to verify the accuracy of all information so obtained. In determining whether to make this investment, Subscriber has relied solely on Subscriber’s own knowledge and understanding of the Company and its business based upon
Subscriber’s own due diligence investigation and the information furnished pursuant to this paragraph. Subscriber understands that no person has been authorized to give any information or to make any representations which were not furnished
pursuant to this Section 2 and Subscriber has not relied on any other representations or information in making its investment decision, whether written or oral, relating to the Company, its operations and/or its prospects. 

2.1.6 Regulation D Offering. Subscriber represents that it is an “accredited investor” as such term is defined in Rule 501(a)
of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”) and acknowledges the sale contemplated hereby is being made in reliance on a private placement exemption to “accredited investors” within
the meaning of Section 501(a) of Regulation D under the Securities Act or similar exemptions under state law. 

 2.1.7 Investment Purposes. The Subscriber is purchasing the Shares solely for
investment purposes, for the Subscriber’s own account and not for the account or benefit of any other person, and not with a view towards the distribution or dissemination thereof. The Subscriber did not decide to enter into this Agreement as a
result of any general solicitation or general advertising within the meaning of Rule 502 under the Securities Act. 
 2.1.8 Restrictions
on Transfer; Shell Company. Subscriber understands the Shares are being offered in a transaction not involving a public offering within the meaning of the Securities Act. Subscriber understands the Shares will be “restricted
securities” within the meaning of Rule 144(a)(3) under the Securities Act and Subscriber understands that the certificates or book-entries representing the Shares will contain a legend in respect of such restrictions. If in the future the
Subscriber decides to offer, resell, pledge or otherwise transfer the Shares, such Shares may be offered, resold, pledged or otherwise transferred only pursuant to: (i) registration under the Securities Act, or (ii) an available exemption
from registration. Subscriber agrees that if any transfer of its Shares or any interest therein is proposed to be made, as a condition precedent to any such transfer, Subscriber may be required to deliver to the Company an opinion of counsel
satisfactory to the Company. Absent registration or an exemption, the Subscriber agrees not to resell the Shares. Subscriber further acknowledges that because the Company is a shell company, Rule 144 may not be available to the Subscriber for the
resale of the Shares until one year following consummation of the initial business combination of the Company, despite technical compliance with the requirements of Rule 144 and the release or waiver of any contractual transfer restrictions. 

2.1.9 No Governmental Consents. No governmental, administrative or other third party consents or approvals are required, necessary or
appropriate on the part of Subscriber in connection with the transactions contemplated by this Agreement. 
 2.2 Company’s
Representations, Warranties and Agreements. To induce the Subscriber to purchase the Shares, the Company hereby represents and warrants to the Subscriber and agrees with the Subscriber as follows: 

2.2.1 Incorporation and Corporate Power. The Company is a Cayman Islands exempted company and is qualified to do business in every
jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite corporate power and authority
necessary to carry out the transactions contemplated by this Agreement. 
 2.2.2 No Conflicts. The execution, delivery and
performance of this Agreement and the consummation by the Company of the transactions contemplated hereby do not violate, conflict with or constitute a default under (i) the Articles, (ii) any agreement, indenture or instrument to which
the Company is a party or (iii) any law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment or decree to which the Company is subject. 

2.2.3 Title to Shares. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Articles, and registration
on the register of members of the Company, the Shares will be duly and validly issued, fully paid and nonassessable. Upon issuance in accordance with, and payment 

 
pursuant to, the terms hereof the Subscriber will have or receive good title to the Shares, free and clear of all liens, claims and encumbrances of any kind, other than (a) transfer
restrictions hereunder and under the other agreements to which the Shares may be subject, (b) transfer restrictions under federal and state securities laws, and (c) liens, claims or encumbrances imposed due to the actions of the
Subscriber. 
 2.2.4 No Adverse Actions. There are no actions, suits, investigations or proceedings pending, threatened against or
affecting the Company which: (i) seek to restrain, enjoin, prevent the consummation of or otherwise affect the transactions contemplated by this Agreement or (ii) question the validity or legality of any transactions or seeks to recover
damages or to obtain other relief in connection with any transactions. 
 2.2.5 Authorization. The Class A Shares issuable upon
conversion of the Class B Shares have been duly authorized and reserved for issuance upon such conversion. 
 3. Surrender and
Cancellation of Shares. 
 3.1 Partial or No Exercise of the Over-allotment Option. In the event the Over-allotment Option
granted to the underwriters of the IPO is not exercised in full, the Subscriber acknowledges and agrees that it (and, if applicable, any transferee of Shares) shall surrender for cancellation any and all rights to such number of Shares (up to an
aggregate of 825,000 Shares and pro rata based upon the percentage of the Over-allotment Option exercised) such that immediately following such surrender, the Subscriber (and any such transferees) will own an aggregate number of Shares (not
including any private placement securities or Class A Shares issuable upon exercise of any warrants or any securities purchased by Subscriber in the IPO or in the aftermarket) equal to 20% of the issued and outstanding Ordinary Shares
immediately following the IPO. 
 3.2 Termination of Rights as Shareholder. If any of the Shares are surrendered and cancelled in
accordance with this Section 3, then after such time the Subscriber (or successor in interest), shall no longer have any rights as a holder of such Shares, and the Company shall take such action as is appropriate to cancel such Shares. 

4. Waiver of Liquidation Distributions; Redemption Rights. 

In connection with the Shares purchased pursuant to this Agreement, the Subscriber hereby waives any and all right, title, interest or claim of
any kind in or to any distributions by the Company from the trust account which will be established for the benefit of the Company’s public shareholders and into which substantially all of the proceeds of the IPO will be deposited (the
“Trust Account”), in the event of a liquidation of the Company upon the Company’s failure to timely complete an initial business combination. For purposes of clarity, in the event the Subscriber purchases securities in the IPO
or in the aftermarket, any Class A Shares so purchased shall be eligible to receive any liquidating distributions by the Company. However, in no event will the Subscriber have the right to redeem any Ordinary Shares held by it into funds held
in the Trust Account upon the successful completion of an initial business combination. 
 5. Restrictions on Transfer. 

5.1 Securities Law Restrictions. In addition to any restrictions to be contained in that certain letter agreement (commonly known as an
“Insider Letter”) dated on or prior to the closing of the IPO by and between Subscriber and the Company, Subscriber agrees not to sell, transfer, pledge, hypothecate or 

 
otherwise dispose of all or any part of the Shares unless, prior thereto (a) a registration statement on the appropriate form under the Securities Act and applicable state securities laws
with respect to the Shares proposed to be transferred shall then be effective or (b) the Company has received an opinion from counsel reasonably satisfactory to the Company, that such registration is not required because such transaction is
exempt from registration under the Securities Act and the rules promulgated by the Securities and Exchange Commission thereunder and with all applicable state securities laws. 

5.2 Lock-up. Subscriber acknowledges that the Shares will be subject to lock-up provisions (the “Lock-up”) contained in the Insider Letter. Pursuant to the Insider Letter, Subscriber will agree (subject to certain exceptions) not
to sell, transfer, pledge, hypothecate or otherwise dispose of all or any part of the Shares until the earlier to occur of: (A) one year after the completion of the Company’s initial business combination or (B) the date on which the
Company completes a liquidation, merger, stock exchange or other similar transaction after its initial business combination that results in all of its shareholders having the right to exchange their Ordinary Shares for cash, securities or other
property. Notwithstanding the foregoing, if the last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial business combination, the Shares will be released from the
Lock-up. 
 5.3 Restrictive Legends. All certificates representing the Shares shall have
endorsed thereon legends substantially as follows: 
 “THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES
ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR
SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL, IS AVAILABLE.” 
 “THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCKUP AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE LOCKUP.” 

5.4 Additional Shares or Substituted Securities. In the event of the declaration of a share capitalization, the declaration of an
extraordinary dividend payable in a form other than Shares, a spin-off, a share sub-division, an adjustment in conversion ratio, a recapitalization or a similar
transaction affecting the Company’s outstanding Ordinary Shares without receipt of consideration, any new, substituted or additional securities or other property which are by reason of such transaction distributed with respect to any Shares
subject to this Section 5 or into which such Shares thereby become convertible shall immediately be subject to this Section 5 and Section 3. Appropriate adjustments to reflect the distribution of such securities or property shall be
made to the number and/or class of Ordinary Shares subject to this Section 5 and Section 3. 
 5.5 Registration Rights.
Subscriber acknowledges that the Shares are being purchased pursuant to an exemption from the registration requirements of the Securities Act and will become freely tradable only after certain conditions are met or they are registered pursuant to a
registration rights agreement to be entered into with the Company prior to the closing of the IPO (the “Registration Rights Agreement”). 

 6. Other Agreements. 

6.1 Further Assurances. Subscriber agrees to execute such further instruments and to take such further action as may reasonably be
necessary to carry out the intent of this Agreement. 
 6.2 Notices. All notices, statements or other documents which are required or
contemplated by this Agreement shall be: (i) in writing and delivered personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing,
(ii) by facsimile to the number most recently provided to such party or such other address or fax number as may be designated in writing by such party and (iii) by electronic mail, to the electronic mail address most recently provided to
such party or such other electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day
following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail. 

6.3 Entire Agreement. This Agreement, together with that certain Insider Letter to be entered into between Subscriber and the Company
and the Registration Rights Agreement, each substantially in the form to be filed as an exhibit to the Registration Statement, embodies the entire agreement and understanding between the Subscriber and the Company with respect to the subject matter
hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. 
 6.4 Modifications
and Amendments. The terms and provisions of this Agreement may be modified or amended only by written agreement executed by all parties hereto. 

6.5 Waivers and Consents. The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted,
only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this
Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent. 

6.6 Assignment. The rights and obligations under this Agreement may not be assigned by either party hereto without the prior written
consent of the other party. 
 6.7 Benefit. All statements, representations, warranties, covenants and agreements in this Agreement
shall be binding on the parties hereto and shall inure to the benefit of the respective successors and permitted assigns of each party hereto. Nothing in this Agreement shall be construed to create any rights or obligations except among the parties
hereto, and no person or entity shall be regarded as a third-party beneficiary of this Agreement. 
 6.8 Governing Law. This
Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and governed by the laws of New York applicable to contracts wholly performed within the borders of such state, without giving effect to the
conflict of law principles thereof. 
 6.9 Severability. In the event that any court of competent jurisdiction shall determine that
any provision, or any portion thereof, contained in this Agreement shall be unreasonable or unenforceable in any respect, then such provision shall be deemed limited to the extent that such court deems it reasonable and enforceable, and as so
limited shall remain in full force and effect. In the event that such court shall deem any such provision, or portion thereof, wholly unenforceable, the remaining provisions of this Agreement shall nevertheless remain in full force and effect. 

 6.10 No Waiver of Rights, Powers and Remedies. No failure or delay by a party hereto
in exercising any right, power or remedy under this Agreement, and no course of dealing between the parties hereto, shall operate as a waiver of any such right, power or remedy of such party. No single or partial exercise of any right, power or
remedy under this Agreement by a party hereto, nor any abandonment or discontinuance of steps to enforce any such right, power or remedy, shall preclude such party from any other or further exercise thereof or the exercise of any other right, power
or remedy hereunder. The election of any remedy by a party hereto shall not constitute a waiver of the right of such party to pursue other available remedies. No notice to or demand on a party not expressly required under this Agreement shall
entitle the party receiving such notice or demand to any other or further notice or demand in similar or other circumstances or constitute a waiver of the rights of the party giving such notice or demand to any other or further action in any
circumstances without such notice or demand. 
 6.11 Survival of Representations and Warranties. All representations and warranties
made by the parties hereto in this Agreement or in any other agreement, certificate or instrument provided for or contemplated hereby, shall survive the execution and delivery hereof and any investigations made by or on behalf of the parties. 

6.12 No Broker or Finder. Each of the parties hereto represents and warrants to the other that no broker, finder or other financial
consultant has acted on its behalf in connection with this Agreement or the transactions contemplated hereby in such a way as to create any liability on the other. Each of the parties hereto agrees to indemnify and save the other harmless from any
claim or demand for commission or other compensation by any broker, finder, financial consultant or similar agent claiming to have been employed by or on behalf of such party and to bear the cost of legal expenses incurred in defending against any
such claim. 
 6.13 Headings and Captions. The headings and captions of the various subdivisions of this Agreement are for
convenience of reference only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof. 

6.14 Counterparts. This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is
delivered by facsimile transmission or any other form of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such
signature page were an original thereof. 
 6.15 Construction. The parties hereto have participated jointly in the negotiation and
drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or disfavoring any
party hereto because of the authorship of any provision of this Agreement. The words “include,” “includes,” and “including” will be deemed to be followed by “without limitation.”
Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words “this
Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of 

 
similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant
contained herein will have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the
same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or covenant. 

6.16 Mutual Drafting. This Agreement is the joint product of the Subscriber and the Company and each provision hereof has been subject
to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto. 
 7.
Voting and Tender of Shares. 
 Subscriber agrees to vote the Shares in favor of an initial business combination that the Company
negotiates and submits for approval to the Company’s shareholders and shall not seek redemption or repurchase with respect to any of the Shares. Additionally, the Subscriber agrees not to tender any Shares in connection with a tender offer
presented to the Company’s shareholders in connection with an initial business combination negotiated by the Company. 
 8.
Indemnification. 
 Each party shall indemnify the other against any loss, cost or damages (including reasonable attorney’s
fees and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant or agreement in this Agreement. 

[Signature Page Follows] 

 If the foregoing accurately sets forth our understanding and agreement, please sign the
enclosed copy of this Agreement and return it to us. 
  

			
	Very truly yours,
	
	BioPlus Acquisition Corp.
		
	By:	 	 /s/ Alan Mendelson

		 	Name: Alan Mendelson
		 	Title: Director

  

			
	 Accepted and agreed, March 18, 2021

	
	BioPlus Sponsor LLC
		
	By:	 	 /s/ Alex Vieux

		 	Name: Alex Vieux
		 	Title: Managing Member
		
	By:	 	 /s/ Steven Fletcher

		 	Name: Steven Fletcher
		 	Title: Managing Member
		
	By:	 	 /s/ Alan Mendelson

		 	Name: Alan Mendelson
		 	Title: Managing Member

 [Signature page to Subscription Agreement]Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

EMPLOYMENT AGREEMENT (this “Employment
Agreement”), dated as of July 14, 2021, between 1847 Goedeker Inc., a Delaware corporation (the “Company”),
and Maria Johnson, an individual (the “Executive”).

 

BACKGROUND

 

The Company wishes to secure the
services of the Executive as Chief Financial Officer of the Company upon the terms and conditions hereinafter set forth, and the Executive
wishes to render such services to the Company upon the terms and conditions hereinafter set forth.

 

AGREEMENT

 

NOW, THEREFORE, in consideration
of the foregoing and the mutual covenants herein contained and for other good and valuable consideration, the receipt and adequacy of
which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

 

1. Employment
by the Company. The Company agrees to employ the Executive in the position of Chief Executive Officer of the Company and have such
duties and responsibilities as are reasonably assigned, delegated and determined as are customarily assigned to individuals serving in
such positions and such other duties consistent with Executive’s title (with such other duties and/or offices in the Company and
its affiliates as may be assigned from time to time by the Company, its Board of Directors, Chief Executive Officer or other senior executive
officers and as agreed to by Executive) and the Executive accepts such employment and agrees to perform such duties. The Executive agrees
to devote the Executive’s full customary business time and energies to the business of the Company and/or its affiliates to perform
the Executive’s duties hereunder.

 

2. Term
of Employment. The term of this Employment Agreement (the “Term”) shall be for the initial period commencing on
July 26, 2021 (the “Effective Date”) and ending on the first anniversary of the Effective Date, unless the Executive
is earlier terminated as provided in Section 4 hereof. The Term shall be automatically extended for successive one-year periods unless
either party provides the other with written notice of non-renewal at least thirty (30) days prior to the end of the initial Term or any
renewal Term.

 

3. Compensation.
As full compensation for all services to be rendered by the Executive to the Company and/or its affiliates in all capacities during the
Term, the Executive shall receive the following compensation and benefits:

 

(a) Salary.
An annual base salary of $385,000 (the “Base Salary”) payable not less frequently than monthly or at more frequent
intervals in accordance with the then customary payroll practices of the Company. In the event of an automatic renewal beyond the initial
one-year Term as set forth in Section 2, Base Salary may be renegotiated by the parties at the time of such renewal.

 

(b) Annual
Bonus. In addition to the Base Salary, the Executive shall be entitled to an annual incentive bonus to the extent the Company achieves
or exceeds the annual EBITDA objectives of the Company which shall be established by the Board of Directors of the Company. The percentage
of Base Salary which the Executive shall be entitled to receive as a bonus is set forth on Exhibit A hereto next to the corresponding
percentage of budgeted EBITDA of the Company which must be achieved in order to earn such bonus level. Any such bonus shall be payable
within thirty (30) days following delivery of the Company’s audited financial statements for the applicable year no later than March
31. For purposes of this Section 3(b), EBITDA of the Company for any period shall mean the sum of the Company’s net earnings (or
loss) before interest expense, income taxes, depreciation and amortization for said period (but excluding any extraordinary gains for
such period), as determined in accordance with generally accepted accounting principles applied on a consistent basis.

 

     

     

    

 

(c) Signing
Bonus. The Company will pay Executive a one-time $15,000 signing bonus, which shall be paid at the first full payroll cycle following
Executive’s start date.

 

(d) Stock
Options. Subject to the approval of the Company’s Board of Directors, Executive shall receive an option to purchase 150,000
shares of the Company’s Common Stock, which option is expected to be granted on or around August 1, 2021. The exercise price of
the option will be equal to the market price per share at the time of issuance. Vesting of the option will occur annually over a 4-year
schedule of 25% per year from the date of issuance. The grant of the option is subject to the terms of the Company’s 2020 Equity
Incentive Plan. The granting of this option shall be subject to the Company obtaining the consent of its (and its affiliates) senior lenders,
if required.

 

(e) Participation
in Employee Benefit Plans; Other Benefits. In addition, the Executive shall be permitted during the Term, if and to the extent eligible,
to participate in all employee benefit plans, including health insurance and the Company’s 401(k) plan, policies and practices now
or hereafter maintained by or on behalf of the Company commensurate with the Executive’s position with the Company. Nothing in this
Employment Agreement shall preclude the Company from terminating or amending any such plans or coverage so as to eliminate, reduce or
otherwise change any benefit payable thereunder, so long as such change similarly affects all Company employees.

 

(f) Expenses.
The Company shall pay or reimburse the Executive for all reasonable and necessary expenses actually incurred or paid by the Executive
during the Term in the performance of the Executive’s duties under this Employment Agreement, upon submission and approval of expense
statements, vouchers or other supporting information in accordance with the then customary practices of the Company.

 

(g) Vacation.
The Executive shall be entitled to four (4) weeks of paid vacation per year.

 

(h) Withholding
of Taxes. The Company may withhold from any benefits payable under this Employment Agreement all federal, state, city and other taxes
as shall be required pursuant to any law or governmental regulation or ruling.

 

4. Termination.

 

(a) Termination
upon Death. If the Executive dies during the Term, this Employment Agreement shall terminate as of the date of the Executive’s
death except in Section 5(b) hereof.

 

(b) Termination
upon Disability. If during the Term the Executive becomes physically or mentally disabled, whether totally or partially, so that the
Executive is unable to perform the Executive’s essential job functions hereunder for a period aggregating 180 days during any
twelve-month period, and it is determined by a physician acceptable to both the Company and the Executive that, by reason of such physical
or mental disability, the Executive shall be unable to perform the essential job functions required of the Executive hereunder for such
period or periods, the Company may, by written notice to the Executive, terminate this Employment Agreement, in which event the Term shall
terminate ten (10) days after the date upon which the Company shall have given notice to the Executive of its intention to terminate this
Employment Agreement because of the disability.

 

    2

     

    

 

(c) Termination
for Cause. The Company may at any time by written notice to the Executive terminate this Employment Agreement immediately and, except
as provided in Section 5(b) hereof, the Executive shall have no right to receive any compensation or benefit hereunder on and after the
date of such notice, in the event that an event of “Cause” occurs. For purposes of this Employment Agreement “Cause”
shall mean:

 

(i) the
Executive’s willful failure to perform Executive’s duties hereunder other than a failure to perform resulting from death or
physical or mental disability) and failure by the Executive to cure such breach within thirty (30) days of written notice thereof from
the Company;

 

(ii) the
commission by the Executive of fraud or intentional material misrepresentation in connection with his employment, including, but not limited
to, misappropriation or embezzlement of any funds of the Company or any of its affiliates;

 

(iii) the
commission by the Executive of any willful misconduct having the effect of materially injuring the reputation, business or business relationships
of the Company or any of its affiliates;

 

(iv) the
entering by the Executive of a plea of guilty or nolo contendere to, or the conviction of the Executive for, a crime involving the unlawful
theft or conversion of monies or other property, or any fraud or embezzlement offense which carries a potential penalty of imprisonment
for more than ninety (90) days and/or a fine in excess of Ten Thousand US Dollars ($10,000);

 

(v) the
Executive’s consistent abuse of alcohol, prescription drugs or controlled substances, which interferes with the performance of his
duties to the Company and which continues after the Company has provided the Executive at least thirty (30) days’ prior written
notice thereof;

 

(vi) the
Executive’s willful disregard of any material rule or policy of the Company and failure to cure the same within thirty (30) days
of written notice thereof from the Company; or

 

(vii) excessive
absenteeism of the Executive other than for reasons of illness that has not been cured, after at least thirty (30) days’ written
notice from the Company with respect thereto.

 

For purposes of this provision,
no act or failure to act on the part of the Executive shall be considered “willful” unless it is done, or omitted to be done,
by the Executive in bad faith or without reasonable belief that the Executive’s action or omission was in the best interests of
the Company. Any act, or failure to act, based on authority given pursuant to a resolution duly adopted by the Board or on the advice
of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by the Executive in good faith and in the
best interests of the Company.

 

Except for a failure, breach, or
refusal which, by its nature, cannot reasonably be expected to be cured, the Executive shall have thirty (30) business days from the delivery
of written notice by the Company within which to cure any acts constituting Cause; provided however, that, if the Company reasonably expects
irreparable injury from a delay of ten (10) business days, the Company may give the Executive notice of such shorter period within which
to cure as is reasonable under the circumstances, which may include the termination of the Executive’s employment without notice and with
immediate effect.

 

    3

     

    

 

(d) Termination
without Cause. The Company may terminate this Employment Agreement at any time, without cause, upon thirty (30) days’ written
notice by the Company to the Executive and, except as provided in Section 5(a) hereof, the Executive shall have no right to receive any
compensation or benefit hereunder after such termination. The Executive may terminate this Employment Agreement at any time, without cause,
upon thirty (30) days’ written notice by the Executive to the Company, provided however that the Executive shall have no right to
receive any compensation, severance or benefit hereunder upon such termination under Section 5.

 

(e) Termination with Good
Reason. The Executive may terminate this Employment Agreement and the Executive’s employment for Good Reason if Company fails
to cure the event constituting Good Reason within thirty (30) days of written notice of such event from the Executive. “Good Reason”
shall mean any of the following that occurs during the Term: 

 

(i) the
reduction of the Executive’s Base Salary and bonus below the amount of the Base Salary and bonus in effect under Section 3 hereof;

 

(ii) the
assignment to the Executive of any duties materially inconsistent with, or a material diminution of the Executive’s duties, offices
or responsibilities from, those of the Executive with Company, or any removal of Executive from or any failure to reelect or reappoint
the Executive to any of such offices, except in connection with the termination of the Executive’s employment for disability (which
cannot be performed without reasonable accommodations), retirement, Cause or as a result of the Executive’s death

 

(iii) a
reduction in the Executive’s stock option compensation as set forth in section 3(d);

 

(iv) the
Company’s material breach of this Employment Agreement; or

 

(v) upon
a “Change of Control.” As used in this Employment Agreement, “Change of Control” shall mean the sale of
all or substantially all the assets of the Company; any merger, consolidation or acquisition of the Company with, by or into another corporation,
entity or person; or any change in the ownership of more than fifty percent (50%) of the voting capital stock of the Company in one or
more related transactions.

 

5. Severance
Payments.

 

(a) Certain
Severance Payments. If during the Term this Employment Agreement is terminated pursuant to Sections 4(d) (but only for termination
of Executive by Company) or 4(e) hereof, all compensation payable to the Executive under Section 3 hereof shall cease as of the date of
termination specified in the Company’s notice (the “Termination Date”), and the Company shall pay to the Executive,
subject to Section 6 hereof, and in addition to any amounts owed to the Executive pursuant to this Agreement for services rendered by
the Executive to the Company prior to such Termination Date, the following sums: (i) the Base Salary on the Termination Date for six (6)
months (the applicable period being referred to as the “Severance Period”), payable in monthly installments over such
time period; (ii) benefits under group health and life insurance plans in which the Executive participated prior to termination through
the Severance Period; (iii) all previously earned, accrued, and unpaid benefits from the Company and its employee benefit plans, including
any such benefits under the Company’s pension, disability, and life insurance plans, policies, and programs; and (iv) so long as
the Company has achieved its budgeted EBITDA level for the period commencing with the end of the Company’s immediately previous
fiscal year through the Termination Date, an amount equal to the product of the bonus paid to the Executive in respect of the immediately
preceding fiscal year pursuant to Section 3(b), times the quotient obtained by dividing (x) the number of full calendar months occurring
since the end of the immediately previous fiscal year through the Termination Date, by (y) 12. If, prior to the date on which the Company’s
obligations under clause (i) of this Section 5(a) cease, the Executive violates Section 6 hereof, then the Company shall have no obligation
to make any of the payments that remain payable by the Company under clauses (i) and (ii) of this Section 5(a) on or after the date of
such violation. The payment of severance as required by this Section 5(a) may be conditioned by the Company on the delivery by the Executive
of a release of any and all claims that the Executive may have against the Company which release shall be in form and substance satisfactory
to the Company.

 

    4

     

    

 

(b) Severance
Payments upon Termination Death, Disability or for Cause. If this Employment Agreement is terminated by the Company pursuant to Sections
4(a), 4(b) or 4(c) hereof, the Executive (or the Executive’s estate or representative as applicable) shall receive only the amounts
specified in clauses (ii), (iii) and (iv) of Section 5(a) hereof.

 

6. Certain
Covenants of the Executive.

 

(a) Covenants
Against Competition. The Executive acknowledges that: (i) the Executive is one of the limited number of persons who will assist with
developing the Company’s business, which consists of owning and operating a retail appliance and furniture business (the “Company’s
Business”); (ii) the Company conducts its business nationwide; (iii) the Executive’s work for the Company will bring the
Executive into close contact with many confidential affairs not readily available to the public; and (iv) the covenants contained in this
Section 6 will not involve a substantial hardship upon the Executive’s future livelihood. In order to induce the Company to enter
into this Employment Agreement, the Executive covenants and agrees that:

 

(i) Non-Compete.
During the Term and for the Severance Period (the “Restricted Period”), the Executive shall not, in those states in
the United States of America in which either the Company or any of its subsidiaries or affiliates then operates a similar business that
falls within the scope of the Company’s Business, directly or indirectly, (i) in any manner whatsoever engage in any capacity with
any business competitive with the Company’s Business for the Executive’s own benefit or for the benefit of any person or entity
other than the Company or affiliate of the Company; or (ii) have any interest as owner, sole proprietor, shareholder, partner, lender,
director, officer, manager, employee, consultant, agent or otherwise in any business competitive with the Company’s Business; provided,
however, that the Executive may hold, directly or indirectly, solely as an investment, not more than two percent (2%) of the outstanding
securities of any person or entity which are listed on any national securities exchange or regularly traded in the over-the-counter market
notwithstanding the fact that such person or entity is engaged in a business competitive with the Company’s Business. In addition,
during the Restricted Period, the Executive shall not develop any property for use in the Company’s Business on behalf of any person
or entity other than the Company, its subsidiaries and affiliates.

 

(ii) Confidential
Information. During the Restricted Period, the Executive shall not, directly or indirectly, disclose to any person or entity who is
not authorized by the Company or any subsidiary or affiliate to receive such information, or use or appropriate for the Executive’s
own benefit or for the benefit of any person or entity other than the Company or any subsidiary or affiliate, any documents or other papers
relating to the Company’s Business or the customers of the Company or any subsidiary or affiliate, including, without limitation,
files, business relationships and accounts, pricing policies, customer lists, computer software and hardware, or any other materials relating
to the Company’s Business or the customers of the Company or any affiliate of the Company or any trade secrets or confidential information,
including, without limitation, any business or operational methods, drawings, sketches, designs or product concepts, know-how, marketing
plans or strategies, product development techniques or plans, business acquisition plans, financial or other performance data, personnel
and other policies of the Company or any affiliate of the Company, whether generated by the Executive or by any other person, except as
required in the course of performing the Executive’s duties hereunder or with the express written consent of the Company; provided,
however, that the confidential information shall not include any information readily ascertainable from public or published information,
or trade sources or independent third parties (other than as a direct or indirect result of unauthorized disclosure by the Executive).

 

    5

     

    

 

(iii) Employees
of and Consultants to the Company. During the Restricted Period, the Executive shall not, directly or indirectly (other than in furtherance
of the business of the Company), initiate communications with, solicit, persuade, entice, induce or encourage any individual who is then
or who has been within the preceding twelve month period, an employee of or consultant to the Company or any of its affiliates to terminate
employment with, or a consulting relationship with, the Company or such affiliate, as the case may be, or to become employed by or enter
into a contract or other agreement with any other person, and the Executive shall not approach any such employee or consultant for any
such purpose or authorize or knowingly approve the taking of any such actions by any other person.

 

(iv) Solicitation
of Customers. During the Restricted Period, the Executive shall not, directly or indirectly, initiate communications with, solicit,
persuade, entice, induce, encourage (or assist in connection with any of the foregoing) any person who is then or has been within the
preceding twelve month period a customer or account of the Company or its affiliates, or any actual customer leads whose identity the
Executive learned during the course of the Executive’s employment with the Company, to terminate or to adversely alter its contractual
or other relationship with the Company or its affiliates.

 

(b) Rights
and Remedies Upon Breach. If the Executive breaches any of the provisions of Section 6(a) hereof (collectively, the “Restrictive
Covenants”), the Company and its affiliates shall, in addition to the rights set forth in Section 6(a) hereof, have the right
and remedy to seek from any court of competent jurisdiction specific performance of the Restrictive Covenants or injunctive relief against
any act which would violate any of the Restrictive Covenants, it being acknowledged and agreed that any such breach may cause irreparable
injury to the Company and its affiliates and that money damages will not provide an adequate remedy to the Company and its affiliates.

 

(c) Severability
of Covenants. If any of the Restrictive Covenants, or any part thereof, is held by a court of competent jurisdiction or any foreign,
federal, state, county or local government or other governmental, regulatory or administrative agency or authority to be invalid, void,
unenforceable or against public policy for any reason, the remainder of the Restrictive Covenants shall remain in full force and effect
and shall in no way be affected, impaired or invalidated, and such court, government, agency or authority shall be empowered to substitute,
to the extent enforceable, provisions similar thereto or other provisions so as to provide to the Company and its affiliates, to the fullest
extent permitted by applicable law, the benefits intended by such provisions.

 

(d) Enforceability
in Jurisdictions. The parties intend to and hereby confer jurisdiction to enforce the Restrictive Covenants upon the courts of any
jurisdiction within the geographical scope of such Restrictive Covenants and only in such jurisdiction where the Executive’s alleged
violation of the Restrictive Covenants occurred. If the courts of any one or more of such jurisdictions hold the Restrictive Covenants
wholly invalid or unenforceable by reason of the breadth of such scope or otherwise, it is the intention of the parties that such determination
not bar or in any way affect the Company’s right to the relief provided above in the courts of any other jurisdiction within the
geographical scope of such Restrictive Covenants, as to breaches of such Restrictive Covenants in such other respective jurisdictions,
such Restrictive Covenants as they relate to each jurisdiction being, for this purpose, severable into diverse and independent covenants.

 

    6

     

    

 

7. Other
Provisions.

 

(a) Notices.
Any notice or other communication required or which may be given hereunder shall be in writing and shall be delivered personally, telecopied,
telegraphed or telexed, or sent by certified, registered or express mail, postage prepaid, to the parties at the addresses specified on
the signature page hereto, or at such other addresses as shall be specified by the parties by like notice, and shall be deemed given so
long as such provides a receipt of delivery, when so delivered personally, telecopied, telegraphed or telexed, or mailed.

 

(b) Entire
Agreement. This Employment Agreement contains the entire agreement between the parties with respect to the subject matter hereof and
supersedes all prior contracts and other agreements, written or oral, with respect thereto.

 

(c) Waivers
and Amendments. This Employment Agreement may be amended, modified, superseded, cancelled, renewed or extended, and the terms and
conditions hereof may be waived, only by a written instrument signed by the parties or, in the case of a waiver, by the party waiving
compliance. No delay on the part of any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof,
nor shall any waiver on the part of any party of any right, power or privilege hereunder, nor any single or partial exercise of any right,
power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder.

 

(d) Governing
Law. This Employment Agreement shall be governed by, and construed in accordance with and subject to, the laws of the State of New
York applicable to agreements made and to be performed entirely within such state.

 

(e) Binding
Effect; Benefit. This Employment Agreement shall inure to the benefit of and be binding upon the parties hereto and any successors
and assigns permitted or required by Section 7(f) hereof. Nothing in this Employment Agreement, expressed or implied, is intended to confer
on any person other than the parties hereto or such successors and assigns, any rights, remedies, obligations or liabilities under or
by reason of this Employment Agreement.

 

(f) Assignment.
This Employment Agreement, and the Executive’s rights and obligations hereunder, may not be assigned by the Executive. The Company
may assign this Employment Agreement and its rights, together with its obligations, hereunder in connection with any sale, transfer or
other disposition of all or substantially all of its assets or business, whether by merger, consolidation or otherwise.

 

(g) Counterparts.
This Employment Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together
shall constitute one and the same instrument.

 

(h) Headings. The headings
in this Employment Agreement are for reference purposes only and shall not in any way affect the meaning or interpretation of this Employment
Agreement.

 

    7

     

    

 

IN WITNESS WHEREOF, the parties
have executed this Employment Agreement as of the date first above written.

 

	 	1847 GOEDEKER INC.
	 	 
	 	By:	 /s/ Douglas T. Moore
	 	Name: Douglas T. Moore
	 	Title: Chief Executive Officer

 

	 	Address:	 
	 	 	 
	 	 	 
	 	 	 

 

	 	EXECUTIVE:
	 	 
	 	/s/ Maria Johnson
	 	Maria Johnson

 

	 	Address:	 
	 	 	 
	 	 	 
	 	 	 

 

     

     

    

 

Exhibit A

 

Bonus Criteria

 

	% of Budgeted EBITDA	 	Bonus as a % of Base Salary	 
	110% or greater	 	 	75	%
	100%	 	 	60	%
	95%	 	 	45	%
	90%	 	 	30	%
	Less than 90%	 	 	0

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]